Stay informed with the latest developments from OraLiva
New collaboration covers non-invasive cytology and AI risk-stratification to dentists across Michigan, Ohio, Indiana, and North Carolina Durham, NC —
NEW YORK, Oct. 6, 2025 — OraLiva, Inc., an AI precision diagnostics company, today announced the close of a $2.0
OraLiva, Inc. is preparing to launch its first noninvasive, AI-powered oral cancer test following recent NIH funding support. The test
OraLiva, Inc. is on the cusp of launching an AI-powered cytology “lab-in-a-kit” platform aimed at transforming early oral cancer diagnosis.
OraLiva, Inc. has been awarded a prestigious Direct to Phase II SBIR grant from the National Institute of Dental and
OraLiva was recently featured on the Slice of Healthcare podcast. In this episode, Denise Marks of the CareQuest Institute of
